Steroid sparing effect of 300IR house dust mite sublingual immunotherapy tablet in house dust mite allergic rhinitis patients

被引：0
|
作者：
Demoly, P. [1 ,2 ]
Pfaar, O. [3 ]
Gevaert, P. [4 ]
Canonica, G. W. [5 ]
Casale, T. [6 ]
Scurati, S. [7 ]
Dolimier, E. [7 ]
机构：
[1] Univ Hosp Montpellier, Montpellier, France
[2] IDESP, Montpellier, France
[3] Philipps Univ Marburg, Univ Hosp Marburg, Marburg, Germany
[4] Univ Ghent, Ghent, Belgium
[5] Humanitas Univ, Milan, Italy
[6] Univ S Florida, Tampa, FL USA
[7] Stallergenes Greer, Antony, France
来源：
ALLERGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
000267
引用
收藏
页码：217 / 218
页数：2
相关论文
共 50 条
  • [41] SAFETY OF HOUSE DUST MITE SUBLINGUAL TABLET FOR THE TREATMENT OF HOUSE DUST MITE-ASSOCIATED ALLERGIC RHINITIS IN ADULTS AND PEDIATRIC SUBJECTS WITH INTERMITTENT ASTHMA
    Parkes, Alicia
    Cognet-Sice, Josiane
    Okamoto, Yoshitaka
    INTERNAL MEDICINE JOURNAL, 2016, 46 : 20 - 20
  • [42] Comparison of subcutaneous and sublingual immunotherapy in house dust mite-induced allergic rhinitis
    Lee, Sang Min
    ALLERGY ASTHMA & RESPIRATORY DISEASE, 2024, 12 (01): : 1 - 2
  • [43] House dust mite sublingual allergen immunotherapy in Southeast Asian population with allergic rhinitis
    Gan, K. L.
    ALLERGY, 2023, 78
  • [44] Sublingual immunotherapy tablet for the treatment of house dust mite allergic rhinitis in Canada: an alternative to minimize treatment costs?
    Ellis, Anne K.
    Gagnon, Remi
    Hammerby, Eva
    Lau, Andrea
    ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2019, 15 (1):
  • [45] Sublingual immunotherapy tablet for the treatment of house dust mite allergic rhinitis in Canada: an alternative to minimize treatment costs?
    Anne K. Ellis
    Rémi Gagnon
    Eva Hammerby
    Andrea Lau
    Allergy, Asthma & Clinical Immunology, 15
  • [46] Reduction in rescue medication use in patients treated with the 300IR house dust mite SLIT tablet
    Pfaar, O.
    Demoly, P.
    Creticos, P.
    De Blay, F.
    Gevaert, P.
    Karagiannis, E.
    Klimek, L.
    Kowal, K.
    Le Gall, M.
    Nenasheva, N.
    Passalacqua, G.
    Tortajada-Girbes, M.
    Vidal, C.
    Worm, M.
    Casale, T.
    ALLERGY, 2020, 75 : 102 - 103
  • [47] The effect of immunotherapy on cross-reactivity between house dust mite and other allergens in house dust mite -sensitized patients with allergic rhinitis
    Zhao, Limin
    Zhang, Yuling
    Zhang, Shujian
    Zhang, Luo
    Lan, Feng
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2021, 17 (09) : 969 - 975
  • [48] Efficacy of a house dust mite sublingual immunotherapy tablet as add-on dupilumab in asthma with rhinitis
    Hoshino, Makoto
    Akitsu, Kenta
    Kubota, Kengo
    Ohtawa, Junichi
    ALLERGOLOGY INTERNATIONAL, 2022, 71 (04) : 490 - 497
  • [49] Efficacy of house dust mite sublingual tablets in an environmental exposure chamber study of patients with house dust mite-associated allergic rhinitis
    Roux, M.
    Yang, W. H.
    Viatte, A.
    Cadic, V
    Zeldin, R. K.
    ALLERGY, 2013, 68 : 5 - 6
  • [50] Sublingual immunotherapy in patients with house dust mite induced allergic rhinitis: a retrospective study of clinical outcome
    Casia, S.
    Thalayasingam, M.
    Shek, L.
    Chao, S.
    ALLERGY, 2012, 67 : 132 - 133
12345